Back to Search
Start Over
VioQuest doses first patient in trial of triciribine-phosphate as leukemia treatment
- Source :
- Science Letter. October 10, 2006, 884
- Publication Year :
- 2006
-
Abstract
- VioQuest Pharmaceuticals, Inc. (VQPH), a New Jersey-based biopharmaceutical company, announced that it has dosed the first patient in its phase 1/2a clinical trial of VQD-002, triciribine-phosphate (TCN-P) at the University [...]
Details
- Language :
- English
- ISSN :
- 15389111
- Database :
- Gale General OneFile
- Journal :
- Science Letter
- Publication Type :
- News
- Accession number :
- edsgcl.246466323